AB-CHMINACA
|
AB-CHMINACA
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
|
| N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | |
| Synthetic cannabinoids | |
| Synthetic cannabinoid receptor agonists |
|
| 1185887-21-1 | |
|
|
InChI=1S/C20H28N4O2/c1-13(2)17(19(21)25)22-20(26)18-15-10-6-7-11-16(15)24(23-18)12-14-8-4-3-5-9-14/h6-7,10-11,13-14,17H,3-5,8-9,12H2,1-2H3,(H2,21,25)(H,22,26)
|
|
KJNZIEGLNLCWTQ-UHFFFAOYSA-N
|
|
|
O=C(C1=NN(CC2CCCCC2)C3=C1C=CC=C3)NC(C(C)C)C(N)=O
|
|
| C20H28N4O2 | |
| 356.4619 g/mol | |
| 71/II | |
| 2018 | |
|
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances.
|